- Home
- AQST vs NEWT Comparison
AQST vs NEWT Comparison
Compare AQST & NEWT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AQST
- NEWT
- Stock Information
- Founded
- AQST 2004
- NEWT 1998
- Country
- AQST United States
- NEWT United States
- Employees
- AQST N/A
- NEWT N/A
- Industry
- AQST Biotechnology: Pharmaceutical Preparations
- NEWT Major Banks
- Sector
- AQST Health Care
- NEWT Finance
- Exchange
- AQST Nasdaq
- NEWT Nasdaq
- Market Cap
- AQST 272.9M
- NEWT 312.9M
- IPO Year
- AQST 2018
- NEWT N/A
- Fundamental
- Price
- AQST $4.06
- NEWT $11.59
- Analyst Decision
- AQST Strong Buy
- NEWT Hold
- Analyst Count
- AQST 7
- NEWT 4
- Target Price
- AQST $11.29
- NEWT $13.75
- AVG Volume (30 Days)
- AQST 1.3M
- NEWT 202.0K
- Earning Date
- AQST 08-05-2025
- NEWT 07-28-2025
- Dividend Yield
- AQST N/A
- NEWT 6.55%
- EPS Growth
- AQST N/A
- NEWT 27.62
- EPS
- AQST N/A
- NEWT 1.92
- Revenue
- AQST $54,228,000.00
- NEWT $352,584,000.00
- Revenue This Year
- AQST N/A
- NEWT N/A
- Revenue Next Year
- AQST $45.71
- NEWT $13.51
- P/E Ratio
- AQST N/A
- NEWT $6.03
- Revenue Growth
- AQST 5.29
- NEWT 23.06
- 52 Week Low
- AQST $2.12
- NEWT $9.12
- 52 Week High
- AQST $5.80
- NEWT $15.49
- Technical
- Relative Strength Index (RSI)
- AQST 72.86
- NEWT 55.52
- Support Level
- AQST $3.62
- NEWT $11.60
- Resistance Level
- AQST $3.80
- NEWT $12.06
- Average True Range (ATR)
- AQST 0.19
- NEWT 0.30
- MACD
- AQST 0.05
- NEWT 0.03
- Stochastic Oscillator
- AQST 95.43
- NEWT 58.33
About AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.
About NEWT NewtekOne Inc.
NewtekOne Inc is a financial holding company engaged in providing financial solutions to its Client Base. It is an internally managed non-diversified closed-end management investment company. It has four reportable segments Banking, Alternative Lending, Technology, NSBF, and Payments.